Role of passive immunotherapies in managing infectious outbreaks

Biologicals

Volumn 40, Issue 3, 2012, Pages 196-199

  Ian Gust, A O ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antisera; Immunoglobulins; Monoclonal antibodies; Outbreaks; Prophylaxis; Therapy

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS A VACCINE; IMMUNOGLOBULIN; MEASLES VACCINE; MONOCLONAL ANTIBODY; RABIES VACCINE; SMALLPOX VACCINE;

ARTICLE; DIPHTHERIA; DISEASE TRANSMISSION; EPIDEMIC; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS A; HOSPITAL INFECTION; HUMAN; IMMUNOTHERAPY; INFECTION; INFLUENZA A (H1N1); MEASLES; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RABIES; SMALLPOX; TETANUS; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; COMMUNICABLE DISEASES; DISEASE OUTBREAKS; HORSES; HUMANS; IMMUNE SERA; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS;

EID: 84860643066     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2012.01.001     Document Type: Article

References (34)

1. Roux E., Yersin A. Contribution a l'etude de la diptherial. Ann Inst Pasteur Paris 1888, 2:629-661.
2. Behring E., Kitasato S. Uber das Zustandekommen der Diptherie - Immunitat and der Tetanus -; Immunitat bie Tieren. Dtsch Med Wochenschr 1890, 16:1113-1114.
3. Simon C.E. An introduction to the study of infection and immunity including chapters or serum therapy, vaccine therapy, chemotherapy and serum diagnosis 1913, Lea and Febiger, Philadelphia Pa, pp. 222-257.
4. Reimann H.A. The pneumonias 1938, The W.B Saunders Co, Philiadelphia, Pa, pp. 149-161.
5. Stokes J., Neefe J.R. Altenuation of infectious hepatitis with gamma globulin:preliminary note. JAMA 1945, 127:144.
6. Stokes J., Maris E.P., Gellis S.S. Chemical, clinical and immunological studies on the products of human plasma fractionation. XI. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prophylaxis and treatment of measles. J Clin Investig 1944, 23:531-540.
7. Havens P., Paul J.R. Prevention of infectious hepatites with gamma globulin. JAMA 1945, 129:129.
8. Liu J.P., Nikolova D., Fei Y. Immunoglobulins fo preventing hepatitis A (review). Cochrane Lib 2010, 9:1-43.
9. Woodson R.D., Clinton J.J. Hepatitis prophylaxis abroad, effectiveness of immune serum globulin in protecting peace corps volunteers. JAMA 1969, 209:1053-1058.
10. Beasley R.P., Chin-Yun Lee G., Roan C.H., Hwang L.Y., Lan C.C., Huang F.Y., et al. Prevention of perinatally transmitted hepatitis B vaccine. Lancet 1983, 2:1099-1102.
11. Simoes E.A.F. Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res 2002, 3:526-533.
12. Palivizimab, a humanized respiratory syncytial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high risk infants. Paediatrics 1998, 102:531-537. RSV Study Group.
13. Bruton O.C. Agammaglobulinaemia. Paediatrics 1952, 9:722-728.
14. Cohn E.J., Oncley J.L., Strong L.E., Huges W.L., Armstrong S.H. Chemical, clinical and immunological studies on the products of human plasma fractionation, 1. The characterization of the protein fractions of human plasma. J Clin Investig 1944, 23:417-432.
15. Nagington J., Gaudy G., Walker J., Walker J.J. Use of normal immunoglobulin in an echovirus II outbreak in a special care baby unit. Lancet Ii 1983, 443-446.
16. Fanaroff A.A., Korones S.B., Wright L.L. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very low birth weight infants, N. Eng. J Med 1994, 330:1107-1113.
17. Ohlsson A., Lacy J.B. Intravenous immunoglobulin for preventing infection in preterm or low birth weight infants. Conchrane Database 2000, 2.
18. Hemming VG. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases. Clin Diag Lab Immunol. (201) 859-863.
19. Cross A.G. Intravenous immunoglobulins (IVIG's) to prevent and treat infectious disease. Adv Exp Med Biol 1995, 383:123-130.
20. Werden K. Supplemental immune globulins in sepsis. Clin Chem Lab Med 1999, 37:341-349.
21. Douzinas E.E., Pitaridis M.T., Louris G., Andrianakis I., Katsouyanni K., Karmpaliotis D., et al. Prevention of infection in multiple trauma patients by high dose intravenous immunoglobulins. Crit Care Med 2000, 28:8-15.
22. Reed E.C., Bowden R.A., Dandliker P.S., Lilleby K.E., Meyers J.D. Treatment of cytomegalovirus pneumonia with gangcyclovir and intravenous cytomegalovirus immunoglobulion in patients with bone marrow transplants. Ann Int Med 1988, 109:783-788.
23. De Vincenzo JP, Hirsh RL, Fuentes RL, Top FH Jr. Use of IV immunoglobulins for treatment of infectious diseases.
24. Erria D.A., Briggil A.M., Sanchez Z. Treatment of argentine haemorrhogic fever. Antivir Res 2008, 78:132-139.
25. Agrawal A.G., Peterson L.R. Human immunoglobulin as a treatment for West Nile virus infections. J Inf Dis 2003, 188:1-4.
26. Ben-Nathan D., Samina I., Orr N. High titre human immunoglobulin as a specific therapy against West Nile virus encephalitis. Hum Vaccines 2010, 6(3):279-281.
27. Nwanegbo E.C., Romanowski E.G., Gordon Y.J., Gambotto A. Efficacy of tropical immunoglobulins against experimental adenoviral ocular infection. Invest Opthalmol Vis Res 2007, 48:4171-4176.
28. Yeh K.M., Chiueh T.S., Siu L.K., Lin J.C., Chan P.K., Peng M.Y., et al. Experience of using convalescent plasma for severe acute respiratory syndrome among health care workers in a Taiwan Hospital. J Antimicrob Chemo 2005, 56:919-922.
29. Luke T.C., Casadevall A., Watowich S.J. Harkback: passive immunotherapty for influenza and other serious infections. Crit Care Med 2010, 38:66-73.
30. Luke T.C., Kilbane E.M., Jackson J.L., Hoffman S.L. Meta analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?. Ann Int Med 2006, 145:599-609.
31. Zhukova E.A. Character of the therapeutic action of different schedules of administration of donor anti-influenza gamma globulin to influenza patients. Tr Inst Im Pastera 1985, 63:47-51.
32. Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, et al. Convalescent plasma for Influenza A (H1N1) 2009 Virus Infection. C.I.D. 52 (2010) 447-456.
33. Wu J.T., Lee C.K., Cowling B.J., Yaren H.Y. Logical feasibility and potential benefits of population-wide passive immunotherapy program during an influenza pandemic. PNAS 2010, 107:3269-3274.
34. Wong H.K., Lee C.K., Hung I.F., Leung J.N., Hong J., Yuen K.Y., et al. Practical limitations of convalescent plasma collections: a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion 2010, 50:1967-1971.